Systemic sclerosis (SSc; scleroderma) has the highest individual mortality of all rheumatic
diseases, and interstitial lung disease (ILD) is among the leading causes of SSc‐related …

There are two major clinical subsets of scleroderma:(i) systemic sclerosis (SSc) is a complex
systemic autoimmune disorder characterized by inflammation, vasculopathy, and excessive …

Systemic sclerosis (SSc) is a systemic, immune-mediated chronic disorder characterized by
small vessel alterations and progressive fibrosis of the skin and internal organs. The …

Objective Interstitial lung disease (ILD) is a common manifestation of connective tissue
disease (CTD) that manifests as several subtypes with significant differences in prognosis. It …

Pirfenidone (PFD) slows the progression of idiopathic pulmonary fibrosis (IPF) by inhibiting
the exaggerated fibrotic response and possibly through additional mechanisms, such as anti …

Introduction Fibrotic interstitial lung disease (ILD) is a frequent and severe complication of
connective tissue disease (CTD). Areas covered In this narrative review, we update the most …

Abstract Purpose of Review This review aims to collate current evidence on the screening,
diagnosis, and treatment of various connective tissue disease (CTD)–associated interstitial …

Systemic sclerosis (SSc) is a severe auto-immune, rheumatic disease, characterized by
excessive fibrosis of the skin and visceral organs. SSc is accompanied by high morbidity …

The management of systemic sclerosis (SSc) is complex, evolving, and requires a
multidisciplinary approach. At diagnosis and throughout the disease course, clinical …

Background Systemic sclerosis (SSc) is an autoimmune disease characterised by severe
vasculopathy and fibrosis of various organs including the lung. Targeted treatment options …